1 / 17

Adolescent Treatment Models: Gender Issues

Gender Differences in Substance Use, Mental Health, and Criminal Justice Involvement of Adolescents at Treatment Entry and Follow Up: Persistent Effects of Treatment Initiative (PETS). Although the world if full of suffering, it is also full of the overcoming of it"-Helen Keller. Overview of PETS.

andrew
Télécharger la présentation

Adolescent Treatment Models: Gender Issues

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

    1. Adolescent Treatment Models: Gender Issues Sally Stevens, Ph.D. Research Professor University of Arizona Southwest Institute for Research on Women 3912 S. 6th Ave. Tucson, AZ 85714 (520) 434-0334 extension 11 Workshop presentation for SAMHSA-CSAT Adolescent Grantee Meeting Washington, DC. February 23-25, 2004

    2. Gender Differences in Substance Use, Mental Health, and Criminal Justice Involvement of Adolescents at Treatment Entry and Follow Up: Persistent Effects of Treatment Initiative (PETS)

    3. Overview of PETS Funded through the Center for Substance Abuse Treatment Merged 7 projects within two large CSAT initiatives Cannabis Youth Treatment (CYT) Adolescent Treatment Models (ATM) Now to the Persistent Effects of Treatment Study This study is funded through the Center for Substance Abuse Treatment via a contract with WESTAT. This study took four projects from the Cannabis Youth Treatment initiative and three projects from the Adolescent Treatment Models initiative. Now to the Persistent Effects of Treatment Study This study is funded through the Center for Substance Abuse Treatment via a contract with WESTAT. This study took four projects from the Cannabis Youth Treatment initiative and three projects from the Adolescent Treatment Models initiative.

    4. Description of Sample Sample of 1,207 adolescents who were enrolled in substance abuse treatment Seventy-nine percent (79%) were boys and 22% were girls Mean age at baseline for the boys was 15.83 and for the girls was 15.66 years old

    5. Gender Differences in Substance Frequency

    10. Conclusions Girls enter treatment with more severe score (worse) in substance use (frequency; problems); general mental health distress; and behavioral complexity compared to boys While the change trajectory was similar for girls and boys, after controlling for treatment type and initial status, the rate of change is actually slower for girls.

    11. Clinical Implications and Treatment Needs (for girls) Earlier identification (schools; primary health care provider; neighborhood centers; religious institutions; LGBT and other special groups; outreach to youth hangouts and streets) Motivational enhancement sessions that can be facilitated in non-traditional settings

    12. Clinical Implications and Treatment Needs (for girls) (cont) Peer based interventions Female-specific treatment based on empowerment theories (emphasis on safety, trauma, stress, relaxation techniques, sleep problems, mental health issues, and behavioral problems)

    13. Do you know your drug slang?

    14. 1. Any kind of alcohol (such as beer, wine, whisky, gin, scotch or mixed drinks) 2 Marijuana, hashish, blunts or other forms THC?. 3. Crack or free base cocaine 4. Other forms of cocaine 5. Inhalants (such as correction fluids, gasoline, glue, lighters, spray paints or paint thinner) 6.Heroin 7. Pain killers, opiates, or other analgesics (such as codeine, Darvocet, Darvon, Demerol, Dilaudid, "Karachi," Percocet, Propoxyphene, street methadone, morphine, opium, Talwin, Ketamine or Tylenol with codeine). 8. PCP (Phencyclidine) 9."Acid" or other hallucinogens ( such as LSD, mushrooms, mescaline, peyote, Ecstasy/MDMA or psilocybin) 10. Anti-anxiety drugs or tranquilizers (such as Ativan, Deprol, Equanil, Diazepam, Klonopin, Meprobamate, Librium, Miltown, Serax, Valium or Xanax) 11."Speed," "uppers," amphetamines, or other stimulants (such as methamphetamine, Biphetamine, Benzedrine, Desoxyn, Dexedrine, Methedrine or Ritalin) 12. "Downers," "sleeping pills," barbiturates or other sedatives (such as Dalmane, Donnatal, Doriden, Flurazepam, Halcion, methaqualone Placidyl, "quaalude," Secobarbital, Seconal, Rohypnol or Tuinal) 99. Some other drug (Please describe)(such as amyl nitrite, cough syrup, nitrous oxide, Nyquil, "poppers" or Robitussin) From the Global Appraisal of Individual Needs (GAIN-I)

    16. The answers are..

    18. Project Implementation Issues in Indian Country Candice Stewart-Sabin Instrumentation issues (GAIN and cultural sensitivity) Data protection Conducting follow-ups

More Related